News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Dana-Farber Cancer Institute
NEWS
JOBS
IN THE PRESS
NEWS
Genetown
Eating Nuts “May Prolong Life,” Dana-Farber Cancer Institute Study
November 21, 2013
·
1 min read
Pharm Country
Obesity Raises Death Risk in Pancreatic Cancer, Dana-Farber Cancer Institute Study
October 22, 2013
·
1 min read
Genetown
Molecule Produced During Exercise Boosts Brain Health, Dana-Farber Cancer Institute and Harvard Medical School Study
October 11, 2013
·
1 min read
Genetown
Newly Discovered Gene Regulator Could Target Sickle Cell Disease, Dana-Farber Cancer Institute and Boston Children’s Cancer and Blood Disorders Center Study
October 11, 2013
·
1 min read
Genetown
Mouth Bacteria May Trigger Colorectal Cancer, Harvard School of Public Health and Dana-Farber Cancer Institute Study
August 15, 2013
·
1 min read
BioMidwest
Cytomegalovirus Might Speed Brain-Cancer Growth, Ohio State University Comprehensive Cancer Center and Dana-Farber Cancer Institute Study
June 3, 2013
·
1 min read
Genetown
Dana-Farber Cancer Institute Scientists Find Mutation Driving Pediatric Brain Tumors
May 1, 2013
·
1 min read
Genetown
Screening Blood Samples for Cancer-Driving Mutations More Comprehensive Than Analyzing Traditional Tumor Biopsy, Dana-Farber Cancer Institute and Harvard Medical School Study
April 8, 2013
·
1 min read
Genetown
Some Incurable BRCA Patients Respond to New 2-Drug Combo, Dana-Farber Cancer Institute Study
April 8, 2013
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Senior Director Of Dana-Farber Cancer Institute, Office For Human Research Studies Joins Schulman IRB As VP For Oncology Services
July 12, 2016
·
2 min read
Business
Dana-Farber Cancer Institute And Fitbit Partner To Test If Weight Loss Can Prevent Breast Cancer Recurrence
April 27, 2016
·
6 min read
Business
Bristol-Myers Squibb And Dana-Farber Cancer Institute Enter Into A Collaboration Agreement As Part Of U.S. Immuno-Oncology Rare Population Malignancy Research Program
February 16, 2016
·
1 min read
Business
Dana-Farber Cancer Institute’s Belfer Center Announces Immuno-Oncology Research Collaboration With Array BioPharma
February 1, 2016
·
6 min read
Business
Transgenomic, Inc. Awarded NIH Grant To Augment Multiplexing Capabilities Of ICE COLD-PCR Technology In Collaboration With Dana-Farber Cancer Institute
December 23, 2015
·
1 min read
Business
Neon Therapeutics Enters License Agreement With The Broad Institute, Dana-Farber Cancer Institute And Massachusetts General Hospital
December 9, 2015
·
4 min read
Genetown
Pan-Mass Challenge Announces Record-Setting $45 Million Gift To Dana-Farber Cancer Institute, Bringing 36-Year Fundraising Total To A Half-Billion Dollars
November 16, 2015
·
4 min read
Drug Development
TRACON Pharmaceuticals, Inc. Reports Ongoing Complete Response In Choriocarcinoma Patient Treated With Company’s TRC105 In Compassionate Use Phase 2 Clinical Trial Conducted At Dana-Farber Cancer Institute
September 18, 2015
·
5 min read
Business
Eli Lilly And Dana-Farber Cancer Institute Announce Research Collaboration
June 17, 2015
·
4 min read
Drug Development
Dana-Farber Cancer Institute And Boston Children’s Hospital Opens Phase I Trial Of Immunotherapy For Children With Relapsed Or Treatment-Resistant Leukemia
May 12, 2015
·
4 min read
